Get In Touch

Cancer is one of the most chronic and fatal disorders, involving abnormal cell growth with potential to spread or invade other parts of the body. Cancer is a life threatening disease, with extremely high mortality rate, due to highly invasive nature. Chemotherapy, abbreviated as, chemo or CTx is an important cancer treatment, in which cancer is treated by using combination of various anti-cancer agents (chemotherapeutic agents) as a part of standard chemotherapeutic regimen. Major drug classes of chemotherapeutic agents include anti-metabolites (purines, pyrimidines), alkylating agents (cisplatins, tetrazines), cytotoxic agents (anthracyclines), anti-microtubule agents (taxanes, vinca derivatives), and others. These drugs are highly effective in cancer treatment, but also cause chronic side effects. Chemotherapy induced pain is the most common side effect, which affects around 30% to 90% of cancer patients. If left untreated, it can affect the daily functions and quality of life as well as lead cancer patients to be less liable to continue their chemotherapy treatment.

Based on type of pain, the global chemotherapy induced pain market can be segmented into bone pain, nerve pain, muscle pain, abdominal pain, breakthrough cancer pain, peripheral neurotherapy, and others. Commonly used chemotherapy drugs such as Cisplatin, Vincristine Sulfate, and Paclitaxel cause chemotherapy induced peripheral neuropathy. In terms of therapy and treatment, the market can be categorized into medicinal treatment and non-medicinal treatment (supportive treatment). Medicinal treatment includes use of non-steroidal anti-inflammatory agents (NSAIDs) (aspirin, paracetamol, nimesulide, ibuprofen, and aceclofenac), opioid drugs (morphine), and others. Non-medicinal treatment includes massage, nutritional treatment, distraction, counseling and consultancy, exercise, and acupuncture. The global chemotherapy induced pain market is expected to experience sustained growth during the forecast period. This is attributed to various factors such as increase in research and development expenditure across the globe and high prevalence rate of cancer. According to the World Health Organization (WHO), cancer accounted for nearly 8.8 million deaths globally in 2015 and this number is projected to reach 13.1 million by 2030. This rapidly growing prevalence of cancer is likely to support the growth of chemotherapy practices which in turn is expected to boost the growth of the market. Owing to extensive R&D, a number of drugs and formulations are under clinical development and expected to enter the market during the forecast period. Moreover, rise in awareness among the population about chemotherapy related pain, increase in medical infrastructure, and technological advancements are projected to propel the market. However, promising pipeline molecules with disappointed results and rise in preference for other cancer treatment options are likely to hamper market growth.

Geographically, the global chemotherapy induced pain market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global chemotherapy induced pain market, followed by Europe, owing to strong clinical pipeline, developed health care infrastructure, and demand for advanced treatment options. Asia Pacific is an emerging market for chemotherapy induced pain treatment due to developing health care infrastructure and rise in government expenditure in the health care industry. Affordability issues, lack of proper treatment, and poor patient education are factors restraining the chemotherapy induced pain market in Middle East & Africa and Latin America.

Major players operating in the chemotherapy induced pain market include Amgen, Inc., Novartis International AG, GlaxoSmithKline plc, AstraZeneca plc, Pfizer, Inc., and Eli Lilly and Company.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Chemotherapy Induced Pain Market

Pre Book